DiaMedica Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2023

	March 31, 2023
Common shares issuable upon exercise of employee and non-employee stock options		2,773,498
Common shares issuable upon settlement of deferred stock units		213,905
Common shares issuable upon vesting of restricted stock units		12,867
Common shares issuable upon exercise of common share purchase warrants		265,000
Shares available for grant under the 2019 Omnibus Incentive Plan		1,899,730
Shares available for grant under the 2021 Employment Inducement Incentive Plan		535,000
Total		5,700,000